However, contrasting results have been reported in the kidney, for which the injection of recombinant NGAL in acute kidney injury provides a benefit20 but NGAL/LCN2 has a deleterious role in CKD progression13,21. This evidence concerns the gene LCN2 and acute kidney injury.